Peter Antinozzi

Affiliations: 
Biochemistry and Molecular Biology Wake Forest University, Winston-Salem, NC, United States 
Area:
Biochemistry, Molecular Biology, Genetics, Oncology
Google:
"Peter Antinozzi"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Redondo MJ, Steck AK, Sosenko J, et al. (2018) Transcription Factor 7-Like 2 () Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes Care
Redondo MJ, Geyer S, Steck AK, et al. (2018) A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care
Redondo MJ, Geyer S, Steck AK, et al. (2017) TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care
Steck AK, Xu P, Geyer S, et al. (2017) Can non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? The Journal of Clinical Endocrinology and Metabolism
Palmer ND, Stevens RD, Antinozzi PA, et al. (2015) Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. The Journal of Clinical Endocrinology and Metabolism. 100: E463-8
Paradis R, Lazar N, Antinozzi P, et al. (2013) Nov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic β-cell function. Plos One. 8: e64957
Murea M, Freedman BI, Parks JS, et al. (2010) Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 2373-9
Melander A, Olsson J, Lindberg G, et al. (1999) 35th Annual Meeting of the European Association for the Study of Diabetes : Brussels, Belgium, 28 September-2 October 1999. Diabetologia. 42: A1-A330
See more...